[Case-control study of risk factors in cholangiocarcinoma]
- PMID: 20021829
[Case-control study of risk factors in cholangiocarcinoma]
Abstract
Objective: To investigate the risk factors of intrahepatic cholangiocarcinoma (ICC) and extrahepatic cholangiocarcinoma (ECC).
Methods: The clinicopathological data of 190 patients with cholangiocarcinomas (61 ICC and 129 ECC) diagnosed and treated in the Peking Union Medical College Hospital between 1998 and 2008 were collected. The clinicopathological data of 380 matched healthy controls were also collected. The information about liver diseases, family history, diabetes, smoking and drinking were recorded and analyzed.
Results: The positive rate of HBsAg(+) and anti-HBc(+), HBsAg(-) and anti-HBc(+) and the incidence of choledocholithiasis or hepatolithiasis in ICC patients were 27.9%, 50.8% and 14.8%, respectively. The incidence of diabetes mellitus, cholecystolithiasis, choledocholithiasis or hepatolithiasis and previous cholecystectomy in ECC patients were 18.6%, 15.5%, 18.6% and 13.2%, respectively. The incidences of all above mentioned factors in the ICC or ECC patients were significantly higher than that in the controls (P < 0.05). Compared with the patients with ECC, the ICC patients had a significantly higher cirrhosis rate (P < 0.05).
Conclusion: Our study results show that choledocholithiasis or hepatolithiasis, liver cirrhosis and chronic HBV infection are possible risk factors for intrahepatic cholangiocarcinoma, while choledocholithiasis or hepatolithiasis, diabetes mellitus, cholecystolithiasis, history of cholecystectomy are risk factors for extrahepatic cholangiocarcinoma.
Similar articles
-
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study.Am J Gastroenterol. 2007 May;102(5):1016-21. doi: 10.1111/j.1572-0241.2007.01104.x. Epub 2007 Feb 23. Am J Gastroenterol. 2007. PMID: 17324130
-
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China.Liver Int. 2010 Feb;30(2):215-21. doi: 10.1111/j.1478-3231.2009.02149.x. Epub 2009 Oct 14. Liver Int. 2010. PMID: 19840244
-
[Risk factors of intrahepatic cholangiocarcinoma: a case-control study].Zhonghua Gan Zang Bing Za Zhi. 2009 Dec;17(12):935-9. Zhonghua Gan Zang Bing Za Zhi. 2009. PMID: 20038337 Chinese.
-
Intrahepatic cholangiocarcinoma: new insights in pathology.Semin Liver Dis. 2011 Feb;31(1):49-60. doi: 10.1055/s-0031-1272839. Epub 2011 Feb 22. Semin Liver Dis. 2011. PMID: 21344350 Review.
-
The epidemiology of cholangiocarcinoma.Semin Liver Dis. 2004 May;24(2):115-25. doi: 10.1055/s-2004-828889. Semin Liver Dis. 2004. PMID: 15192785 Review.
Cited by
-
Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies.World J Surg Oncol. 2015 Apr 23;13:161. doi: 10.1186/s12957-015-0583-9. World J Surg Oncol. 2015. PMID: 25903488 Free PMC article.
-
Viral hepatitis increases the risk of cholangiocarcinoma: a systematic review and meta-analysis.Transl Cancer Res. 2023 Jun 30;12(6):1602-1616. doi: 10.21037/tcr-23-892. Epub 2023 Jun 26. Transl Cancer Res. 2023. PMID: 37434689 Free PMC article.
-
Systematic review and meta-analysis: cholecystectomy and the risk of cholangiocarcinoma.Oncotarget. 2017 Jul 26;8(35):59648-59657. doi: 10.18632/oncotarget.19570. eCollection 2017 Aug 29. Oncotarget. 2017. PMID: 28938668 Free PMC article.
-
Epidemiology of biliary tract cancer in China: A narrative review.Chin J Cancer Res. 2024 Oct 30;36(5):474-488. doi: 10.21147/j.issn.1000-9604.2024.05.02. Chin J Cancer Res. 2024. PMID: 39539810 Free PMC article.
-
Smoking and risk of cholangiocarcinoma: a systematic review and meta-analysis.Oncotarget. 2017 Aug 10;8(59):100570-100581. doi: 10.18632/oncotarget.20141. eCollection 2017 Nov 21. Oncotarget. 2017. PMID: 29246002 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical